Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

ClinicalTrials.gov ID: NCT04221230

Public ClinicalTrials.gov record NCT04221230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A proof of concept (POC) study evaluating the impact of NMRA-335140 (BTRX-335140) relative to placebo on symptoms of major depressive disorder (MDD) in adult participants with MDD and symptoms of anhedonia and anxiety following 8 weeks of double-blind treatment as assessed by the HAMD-17 Scale.

Study identification

NCT ID
NCT04221230
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neumora Therapeutics, Inc.
Industry
Enrollment
204 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2, 2020
Primary completion
Apr 7, 2022
Completion
Jun 22, 2022
Last update posted
May 28, 2025

2020 – 2022

United States locations

U.S. sites
38
U.S. states
13
U.S. cities
35
Facility City State ZIP Site status
Neumora Investigator Site Phoenix Arizona 85016
Neumora Investigator Site Bentonville Arkansas 72712
Neumora Investigator Site Little Rock Arkansas 72211
Neumora Investigator Site Bellflower California 90706
Neumora Investigator Site Culver City California 90230
Neumora Investigator Site Garden Grove California 92845
Neumora Investigator Site Glendale California 91206
Neumora Investigator Site Long Beach California 90807
Neumora Investigator Site Oakland California 94607
Neumora Investigator Site Riverside California 92506
Neumora Investigator Site San Jose California 95124
Neumora Investigator Site Santa Ana California 92705
Neumora Investigator Site Sherman Oaks California 91403
Neumora Investigator Site Torrance California 90502
Neumora Investigator Site Upland California 91786
Neumora Investigator Site Fernandina Beach Florida 32034
Neumora Investigator Site Jacksonville Florida 32256
Neumora Investigator Site Lauderhill Florida 33319
Neumora Investigator Site Miami Lakes Florida 33016
Neumora Investigator Site Orlando Florida 32751
Neumora Investigator Site Orlando Florida 32801
Neumora Investigator Site Sarasota Florida 34243
Neumora Investigator Site Atlanta Georgia 30328
Neumora Investigator Site Atlanta Georgia 30331
Neumora Investigator Site Atlanta Georgia 30338
Neumora Investigator Site Decatur Georgia 30030
Neumora Investigator Site Las Vegas Nevada 89102
Neumora Investigator Site Berlin New Jersey 08009
Neumora Investigator Site Brooklyn New York 11229
Neumora Investigator Site Jamaica New York 11432
Neumora Investigator Site New York New York 10036
Neumora Investigator Site Rochester New York 14618
Neumora Investigator Site Staten Island New York 10312
Neumora Investigator Site Dayton Ohio 45417
Neumora Investigator Site Oklahoma City Oklahoma 73112
Neumora Investigator Site Memphis Tennessee 38119
Neumora Investigator Site Wichita Falls Texas 76309
Neumora Investigator Site Clinton Utah 84015

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04221230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2025 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04221230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →